Risk of complications and uterine malignancies in women undergoing hysterectomy for presumed benign leiomyomas

Gynecologic and Obstetric Investigation

Volumn 48, Issue 3, 1999, Pages 193-196

  Takamizawa, Satoru ^a   Minakami, Hisanori ^a   Usui, Rie ^a   Noguchi, Saori ^a   Ohwada, Michitaka ^a   Suzuki, Mitsuaki ^a   Sato, Ikuo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Complications; Hysterectomy; Leiomyoma; Leiomyosarcoma

Indexed keywords

ABDOMINAL BLEEDING; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; ENDOMETRIUM CARCINOMA; ENDOMETRIUM SARCOMA; FEMALE; HUMAN; HYSTERECTOMY; INTESTINE INJURY; LEIOMYOSARCOMA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; OPERATION DURATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REOPERATION; RETROSPECTIVE STUDY; RISK ASSESSMENT; URINARY TRACT INJURY; UTERUS MYOMA;

ADULT; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; INTESTINES; LEIOMYOMA; LEIOMYOSARCOMA; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOMA, ENDOMETRIAL STROMAL; URINARY TRACT; UTERINE NEOPLASMS;

EID: 0032884622     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000010172     Document Type: Article

References (16)

1. Friedman AJ, Hoffman DI, Comite F, Browneller RW, Miller JD: Treatment of leiomyomata uteri with leuprolide acetate depot: Double-blind, placebo-controlled, multicenter study. Obstet Gynecol 1991;77:720-725.
2. Matta WHM, Shaw RW, Nye M: Long-term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin. Br J Obstet Gynaecol 1989;96:200-206.
3. Friedman AJ: Treatment of leiomyomata uteri with short-term leuprolide followed by leuprolide plus estrogen-progestin hormone replacement therapy for 2 years: A pilot study. Fertil Steril 1989;51:526-528.
4. Friedman AJ, Daly M, Juneau-Norcross M, Rein MS, Fine C, Gleason R, Leboff M: A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin 'add-back' regimens for women with leiomyomata uteri. J Clin Endocrinol Metab 1993;76:1439-1445.
5. Wingo PA, Huezo CM, Rubin GL, Ory HW, Peterson HB: The mortality risk associated with hysterectomy. Am J Obstet Gynecol 1985; 152:803-808.
6. Dicker RC, Greenspan JR, Strauss LT, Cowart MR, Scally MJ, Peterson HB, DeStefano F, Rubin GL, Ory HW: Complication of abdominal and vaginal hysterectomy among women of reproductive age in the United States. Am J Obstet Gynecol 1982;144:841-848.
7. Leibsohn S, d'Ablaing G, Mishell DRJr, Schlaerth JB: Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol 1990: 162:968-976.
8. Parker WH, Fu YS, Berek JS: Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 1994;83:414-418.
9. Amirikia H, Evans TN: Ten-year review of hysterectomies: trends, indications, and risks. Am J Obstet Gynecol 1979;134:431-437.
10. Chryssikopoulos A, Loghis C: Indications and results of total hysterectomy. Int Surg 1986;71: 188-194.
11. Gambone JC, Reiter RC, Lench JB: Quality assurance indicators and short-term outcome of hysterectomy. Obstet Gynecol 1990,76:841-845.
12. Chan YGS, Ho HK, Chen CYH: Abdominal hysterectomy: indications and complications. Singapore Med J 1993;34:337-340.
13. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP: Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995;332:912-917.
14. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RH, Rosendaal FR: increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994;344:1453-1457.
15. Bloemenkamp KWM, Rosendaal FR, Helmerhorst FM, Buller HR, Vandenbroucke JP: Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing third-generation progestagen. Lancet 1995;346:1593-1596.
16. Ridker PM, Miletich JP, Hennekens CH, Buring JE: Ethnic distribution of factor V Leiden in 4,047 men and women. JAMA 1997;277: 1305-1307.